amifostine anhydrous has been researched along with technetium tc 99m dimercaptosuccinic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altaner, S; Caloglu, M; Cermik, TF; Cosar-Alas, R; Kaldir, M; Kocak, Z; Parlar, S; Saynak, M; Tokatli, F; Türe, M; Uzal, C; Yurut-Caloglu, V | 1 |
1 other study(ies) available for amifostine anhydrous and technetium tc 99m dimercaptosuccinic acid
Article | Year |
---|---|
Amifostine use in radiation-induced kidney damage. Preclinical evaluation with scintigraphic and histopathologic parameters.
Topics: Amifostine; Animals; Female; Injections, Intraperitoneal; Kidney; Kidney Function Tests; Kidney Tubules; Premedication; Radiation Injuries; Radiation-Protective Agents; Radionuclide Imaging; Rats; Technetium Tc 99m Dimercaptosuccinic Acid | 2008 |